Logo image of CHRD

CHORD ENERGY CORP (CHRD) Stock Fundamental Analysis

NASDAQ:CHRD - Nasdaq - US6742152076 - Common Stock - Currency: USD

112.04  +1.07 (+0.96%)

After market: 112.5 +0.46 (+0.41%)

Fundamental Rating

5

Taking everything into account, CHRD scores 5 out of 10 in our fundamental rating. CHRD was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. CHRD has an average financial health and profitability rating. CHRD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CHRD had positive earnings in the past year.
In the past year CHRD had a positive cash flow from operations.
In multiple years CHRD reported negative net income over the last 5 years.
In the past 5 years CHRD always reported a positive cash flow from operatings.
CHRD Yearly Net Income VS EBIT VS OCF VS FCFCHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B -3B

1.2 Ratios

CHRD's Return On Assets of 7.18% is fine compared to the rest of the industry. CHRD outperforms 63.59% of its industry peers.
CHRD's Return On Equity of 10.66% is in line compared to the rest of the industry. CHRD outperforms 48.06% of its industry peers.
CHRD has a Return On Invested Capital of 7.87%. This is comparable to the rest of the industry: CHRD outperforms 53.88% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHRD is significantly below the industry average of 28.73%.
The 3 year average ROIC (21.58%) for CHRD is well above the current ROIC(7.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.18%
ROE 10.66%
ROIC 7.87%
ROA(3y)17.76%
ROA(5y)-23.87%
ROE(3y)30.24%
ROE(5y)-63.14%
ROIC(3y)21.58%
ROIC(5y)13.98%
CHRD Yearly ROA, ROE, ROICCHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

Looking at the Profit Margin, with a value of 19.66%, CHRD is in the better half of the industry, outperforming 67.48% of the companies in the same industry.
The Operating Margin of CHRD (24.59%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CHRD has grown nicely.
CHRD has a Gross Margin (53.34%) which is in line with its industry peers.
CHRD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.59%
PM (TTM) 19.66%
GM 53.34%
OM growth 3Y65.82%
OM growth 5Y9.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.37%
GM growth 5Y-0.69%
CHRD Yearly Profit, Operating, Gross MarginsCHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHRD is creating value.
CHRD has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHRD has less shares outstanding
Compared to 1 year ago, CHRD has an improved debt to assets ratio.
CHRD Yearly Shares OutstandingCHRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
CHRD Yearly Total Debt VS Total AssetsCHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.84 indicates that CHRD is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHRD has a Altman-Z score (1.84) which is comparable to the rest of the industry.
The Debt to FCF ratio of CHRD is 3.09, which is a good value as it means it would take CHRD, 3.09 years of fcf income to pay off all of its debts.
CHRD has a Debt to FCF ratio of 3.09. This is in the better half of the industry: CHRD outperforms 70.39% of its industry peers.
CHRD has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CHRD has a Debt to Equity ratio of 0.10. This is in the better half of the industry: CHRD outperforms 78.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.09
Altman-Z 1.84
ROIC/WACC0.88
WACC8.96%
CHRD Yearly LT Debt VS Equity VS FCFCHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

2.3 Liquidity

CHRD has a Current Ratio of 0.93. This is a bad value and indicates that CHRD is not financially healthy enough and could expect problems in meeting its short term obligations.
CHRD has a worse Current ratio (0.93) than 67.96% of its industry peers.
A Quick Ratio of 0.89 indicates that CHRD may have some problems paying its short term obligations.
The Quick ratio of CHRD (0.89) is worse than 62.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.89
CHRD Yearly Current Assets VS Current LiabilitesCHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

4

3. Growth

3.1 Past

CHRD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.26%.
The Revenue has grown by 20.61% in the past year. This is a very strong growth!
CHRD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.91% yearly.
EPS 1Y (TTM)-8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.54%
Revenue 1Y (TTM)20.61%
Revenue growth 3Y53.22%
Revenue growth 5Y10.91%
Sales Q2Q%29.12%

3.2 Future

Based on estimates for the next years, CHRD will show a decrease in Earnings Per Share. The EPS will decrease by -5.71% on average per year.
The Revenue is expected to grow by 10.79% on average over the next years. This is quite good.
EPS Next Y-20.16%
EPS Next 2Y-19.33%
EPS Next 3Y-10.17%
EPS Next 5Y-5.71%
Revenue Next Year38.41%
Revenue Next 2Y15%
Revenue Next 3Y10.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CHRD Yearly Revenue VS EstimatesCHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CHRD Yearly EPS VS EstimatesCHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.08 indicates a rather cheap valuation of CHRD.
Based on the Price/Earnings ratio, CHRD is valued cheaper than 83.50% of the companies in the same industry.
CHRD is valuated cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.58 indicates a reasonable valuation of CHRD.
Based on the Price/Forward Earnings ratio, CHRD is valued a bit cheaper than the industry average as 71.84% of the companies are valued more expensively.
CHRD is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.08
Fwd PE 8.58
CHRD Price Earnings VS Forward Price EarningsCHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

76.70% of the companies in the same industry are more expensive than CHRD, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as CHRD.
Industry RankSector Rank
P/FCF 24.37
EV/EBITDA 3.63
CHRD Per share dataCHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

A cheap valuation may be justified as CHRD's earnings are expected to decrease with -10.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.33%
EPS Next 3Y-10.17%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.32%, CHRD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.57, CHRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, CHRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.32%

5.2 History

CHRD has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CHRD Yearly Dividends per shareCHRD Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 5 10 15 20 25

5.3 Sustainability

CHRD pays out 58.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.05%
EPS Next 2Y-19.33%
EPS Next 3Y-10.17%
CHRD Yearly Income VS Free CF VS DividendCHRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B -3B
CHRD Dividend Payout.CHRD Dividend Payout, showing the Payout Ratio.CHRD Dividend Payout.PayoutRetained Earnings

CHORD ENERGY CORP

NASDAQ:CHRD (2/4/2025, 8:00:00 PM)

After market: 112.5 +0.46 (+0.41%)

112.04

+1.07 (+0.96%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners94.79%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner Change-3.14%
Market Cap6.85B
Analysts81.9
Price Target170.34 (52.03%)
Short Float %2.67%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield 4.32%
Yearly Dividend12.09
Dividend Growth(5Y)N/A
DP58.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.56%
Min EPS beat(2)-11.89%
Max EPS beat(2)-7.22%
EPS beat(4)2
Avg EPS beat(4)-3.16%
Min EPS beat(4)-11.89%
Max EPS beat(4)3.48%
EPS beat(8)3
Avg EPS beat(8)0.67%
EPS beat(12)5
Avg EPS beat(12)0%
EPS beat(16)8
Avg EPS beat(16)5.89%
Revenue beat(2)2
Avg Revenue beat(2)16.41%
Min Revenue beat(2)9.22%
Max Revenue beat(2)23.6%
Revenue beat(4)4
Avg Revenue beat(4)19.54%
Min Revenue beat(4)8.87%
Max Revenue beat(4)36.47%
Revenue beat(8)8
Avg Revenue beat(8)22.35%
Revenue beat(12)12
Avg Revenue beat(12)35.63%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.19%
PT rev (3m)-8.28%
EPS NQ rev (1m)-8.38%
EPS NQ rev (3m)-49.93%
EPS NY rev (1m)-2.22%
EPS NY rev (3m)-20.6%
Revenue NQ rev (1m)-0.64%
Revenue NQ rev (3m)-8.29%
Revenue NY rev (1m)1.33%
Revenue NY rev (3m)5.02%
Valuation
Industry RankSector Rank
PE 6.08
Fwd PE 8.58
P/S 1.44
P/FCF 24.37
P/OCF 3.3
P/B 0.78
P/tB 0.83
EV/EBITDA 3.63
EPS(TTM)18.44
EY16.46%
EPS(NY)13.06
Fwd EY11.66%
FCF(TTM)4.6
FCFY4.1%
OCF(TTM)33.93
OCFY30.28%
SpS77.88
BVpS143.58
TBVpS134.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.18%
ROE 10.66%
ROCE 10.3%
ROIC 7.87%
ROICexc 7.91%
ROICexgc 8.3%
OM 24.59%
PM (TTM) 19.66%
GM 53.34%
FCFM 5.9%
ROA(3y)17.76%
ROA(5y)-23.87%
ROE(3y)30.24%
ROE(5y)-63.14%
ROIC(3y)21.58%
ROIC(5y)13.98%
ROICexc(3y)23.75%
ROICexc(5y)15.29%
ROICexgc(3y)23.75%
ROICexgc(5y)15.33%
ROCE(3y)28.22%
ROCE(5y)18.28%
ROICexcg growth 3Y71.97%
ROICexcg growth 5Y28.13%
ROICexc growth 3Y75.76%
ROICexc growth 5Y28.13%
OM growth 3Y65.82%
OM growth 5Y9.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.37%
GM growth 5Y-0.69%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.09
Debt/EBITDA 0.41
Cap/Depr 193.96%
Cap/Sales 37.66%
Interest Coverage 250
Cash Conversion 98.98%
Profit Quality 30.02%
Current Ratio 0.93
Quick Ratio 0.89
Altman-Z 1.84
F-Score4
WACC8.96%
ROIC/WACC0.88
Cap/Depr(3y)287.55%
Cap/Depr(5y)217.4%
Cap/Sales(3y)32.64%
Cap/Sales(5y)34.49%
Profit Quality(3y)54.66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.54%
EPS Next Y-20.16%
EPS Next 2Y-19.33%
EPS Next 3Y-10.17%
EPS Next 5Y-5.71%
Revenue 1Y (TTM)20.61%
Revenue growth 3Y53.22%
Revenue growth 5Y10.91%
Sales Q2Q%29.12%
Revenue Next Year38.41%
Revenue Next 2Y15%
Revenue Next 3Y10.79%
Revenue Next 5YN/A
EBIT growth 1Y-13.11%
EBIT growth 3Y154.07%
EBIT growth 5Y21.87%
EBIT Next Year84.89%
EBIT Next 3Y28.09%
EBIT Next 5Y21.5%
FCF growth 1Y-62.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.94%
OCF growth 3Y82.74%
OCF growth 5Y12.8%